Nuclear insulin receptor substrate 1 interacts with estrogen receptor α at ERE promoters

Oncogene

Volumn 23, Issue 45, 2004, Pages 7517-7526

  Morelli, Catia ^a,b   Garofalo, Cecilia ^a,b   Sisci, Diego ^a,b   Del Rincon, Sonia ^c   Cascio, Sandra ^a,d   Tu, Xiao ^a   Vecchione, Andrea ^a   Sauter, Edward R ^e   Miller Jr , Wilson H ^c   Surmacz, Eva ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF CALABRIA   (Italy)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF PALERMO   (Italy)

^e UNIVERSITY OF MISSOURI   (United States)

Author keywords

Breast cancer; Estrogen receptor ; Estrogen responsive elements; Insulin like growth factor; Nuclear insulin receptor substrate 1

Indexed keywords

DNA; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; PROTEIN PS2; SOMATOMEDIN C RECEPTOR;

ARTICLE; BREAST CANCER; CELL NUCLEUS; CELL STRAIN MCF 7; ESTROGEN RESPONSIVE ELEMENT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRECIPITATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; DNA PRIMERS; ESTROGEN RECEPTOR ALPHA; HUMANS; PHOSPHOPROTEINS; PRECIPITIN TESTS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

MINK CELL FOCUS-FORMING VIRUS;

EID: 6344279925     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208014     Document Type: Article

References (34)

1. Ando S, Panno ML, Salerno M, Sisci D, Mauro L, Lanzino M and Surmacz E. (1998). Biochem. Biophys. Res. Commun., 253, 315-319.
2. Bartucci M, Morelli C, Mauro L, Ando' S and Surmacz E. (2001). Cancer Res., 61, 6747-6754.
3. Boylan JM and Gruppuso PA. (2002). Endocrinology, 143, 4178-4183.
4. Burks DJ and White MF. (2001). Diabeles, 50, S140-S145.
5. Chan TW, Pollak M and Huynh H. (2001). Clin. Cancer Res., 7, 2545-2554.
6. Guvakova MA and Surmacz E. (1997). Cancer Res., 57, 2606-2610.
7. Kahlert S, Nuedling S, van Eickels M, Vetter H, Meyer R and Grohe' C. (2000). J. Biol. Chem., 275, 18447-18453.
8. Lannigan DA. (2003). Steroids, 68, 1-9.
9. Lassak A, Del Valle L, Peruzzi F, Wang JY, Enam S, Croul S, Khalili K and Reiss K. (2002). J. Biol. Chem., 277, 17231-17238.
10. Lee AV, Jackson JG, Gooch JL, Hilsenbeck SG, Coronado-Heinsohn E, Osborne CK and Yee D. (1999). Mol. Endocrinol., 10, 787-796.
11. Maggiolini M, Bonofiglio D, Marsico S, Panno ML, Cenni B, Picard D and Andò S. (2001). Mol. Pharmacol., 60, 595-602.
12. Mauro L, Salerno M, Panno ML, Bellizzi D, Sisci D, Miglietta A, Surmacz E and Ando S. (2001). Biochem. Biophys. Res. Commun., 288, 685-689.
13. Metiver R, Stark A, Flouriot G, Hubner MR, Brand H, Penot G, Manu D, Denger S, Reid G, Kos M, Russel RB, Kah O, Pakdel F and Gannon F. (2002). Mol. Cell, 10, 1019-1032.
14. Molloy CA, May FEB and Westley BR. (2000). J. Biol. Chem., 275, 12565-12571.
15. Morelli C, Garofalo C, Bartucci M and Surmacz E. (2003). Oncogene, 22, 4007-4016.
16. Prisco M, Santini F, Baffa R, Liu M, Drakas R, Wu A and Baserga R. (2002). J. Biol. Chem., 277, 32078-32085.
17. Reid G, Hubner M R, Metivier R, Brard H, Denger S, Manu D, Beaudouin J, Ellenberg J and Gannon F. (2003). Mol. Cell, 11, 695-707.
18. Sachdev D and Yee D. (2001). Endocr. Relat. Cancer, 8, 197-209.
19. Salerno M, Sisci D, Mauro L, Guvakova M, Ando S and Surmacz E. (1999). Int. J. Cancer, 81, 299-304.
20. Schnarr B, Strunz K, Ohsam J, Benner A, Wacker J and Mayer D. (2000). Int. J. Cancer, 89, 506-513.
21. Sciacca L, Prisco M, Wu A, Belfiore A, Vigneri R and Baserga R. (2003). Endocrinology, 144, 2650-2658.
22. Seol KC and Kim SJ. (2003). Biochem. Biophys. Res. Commun., 306, 898-904.
23. Shang Y, Hu X, DiRenzo J, Lazar MA and Brown M. (2000). Cell, 103, 843-852.
24. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW and Liao JK. (2000). Nature, 407, 538-541.
25. Song R, Mcpherson RA, Adam L, Bao Y, Shupnik M, Kumar R and Santen RJ. (2002). Mol. Endocrinol., 16, 116-127.
26. Sun H, Tu X, Prisco M, Wu A, Casaburi I and Baserga R. (2003). Mol. Endocrinol., 17, 472-486.
27. Sun M, Paciga JE, Feldman RI, Yuan Z, Coppola D, Lu YY, Shelley SA, Nicosia SV and Cheng JQ. (2001). Cancer Res., 61, 5985-5991.
28. Surmacz E. (2000). J. Mammary Gland Biol. Neopl., 5, 95-105.
29. Surmacz E and Burgaud JL. (1995). Clin. Cancer Res., 1, 1429-1436.
30. Tu X, Batta P, Innocent N, Prisco M, Casaburi I, Belletti B and Baserga R. (2002). J. Biol. Chem., 277, 44357-44365.
31. Vladusic EA, Hornby AE, Guerra-Vladusic FK, Lakins J and Lupu R. (2000). Oncol. Rep., 7, 157-167.
32. White MF. (1998). Mol. Cell. Biochem., 182, 3-11.
33. Yee D and Lee AVJ. (2000). J Mammary Gland Biol. Neopl., 5, 107-115.
34. Yenush L and White MF. (1997). BioEssays, 19, 491-500.